4,5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators

Details for Australian Patent Application No. 2008263915 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Van Vliet, Bernard J.; Yildirim, Mahmut; Wals, Hendrik C.; Lange, Josephus H.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008263915

PCT Pub. Number WO2008/152086

Priority 07110327.9 15.06.07 EP; 60/944,194 15.06.07 US

Filing date 12 June 2008

Wipo publication date 18 December 2008

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

11 February 2010 PCT application entered the National Phase

  PCT publication WO2008/152086 Priority application(s): WO2008/152086

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008263920-Pesticidal composition comprising a strigolactone derivative and an insecticide compound

2008263907-Low-voc aqueous hybrid binder